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The ccNexfin monitor is a noninvasive device permit-ting beat-to-beat moni-toring of blood pressure 
and flow, cardiac function and fluid 
dynamics. Whereas continuous or 
advanced hemodynamic monitoring 
is normally restricted to a small selec-
tion of (major) surgical procedures, 
this new technology offers the chance 
of using its advantages in our whole 
patient population in a beneficially 
fast and noninvasive fashion. 
During routine anesthesia practice, 
blood pressure and heart rate nor-
mally are the main variables used to 
assess the patient’s hemodynamic 
condition. Continuous and precise 
assessment of blood pressure via an 
arterial line is always most desirable, 
however this is only used in a minor-
ity of cases because of its invasive and 
laborious nature and costs. In addi-
tion, while blood pressure and heart 
rate may provide a satisfying picture 
of the patient’s hemodynamic condi-
tion, it gives an inaccurate reflection 
of blood flow, tissue oxygenation 
and fluid balance. In particular, the 
use of sympathomimetic drugs often 
restores blood pressure at the expense 
of blood flow and tissue oxygenation, 
while hypovolemia/blood loss only 
induce changes in blood pressure or 
heart rate after major deficits due to 
compensatory sympathoadrenergic 
stimulation/centralization [1]. In 
both cases, blood pressure and heart 
rate poorly reflect tissue perfusion 
and oxygenation. For decades now, 
we have the clinical availability of 
advanced hemodynamic monitoring 
that can provide beat-to-beat infor-
mation on flow- and volume related 
variables such as stroke volume, car-
diac output, fluid responsiveness and 
preload status, but the invasiveness 
of most of these techniques restricts 
their use to major surgery and/or high 
risk patients and in addition may be 
the cause of important iatrogenous 
morbidity.
Growing evidence supports the im-
portance of goal directed fluid thera-
py [2] and meticulous blood pressure 
management. This endorses the im-
portance of beat-to-beat monitoring 
to allow fast intervention in case of 
swift hemodynamic changes, together 
with the use of dynamic preload vari-
ables to guide fluid management and 
preserve euvolemia [3]. While moni-
toring of these variables until recently 
required invasive methods and/or 
specific skills including a considerable 
learning curve, new technological ad-
vancements such as ccNexfin permit 
noninvasive beat-to-beat assessment 
of blood pressure, blood flow, cardiac 
function and fluid responsiveness in a 
very intuitive fashion.
Technological background
In the ccNexfin monitor, two ad-
vanced technologies work in concert 
to measure and calculate the variables 
of interest to the clinician. Using the 
volume clamp method the arterial 
pressure waveform is measured, and 
secondly advanced pulse-contour 
analysis algorithms calculate stroke 
volume (and thus cardiac output). 
These variables also allow computa-
tion of dynamic preload variables.
Volume clamp method
The principle of volume clamping 
was invented by the Czech physiolo-
gist Jan Peňáz and further developed 
by Wesseling in the 1980s resulting in 
the commercially available Finapres™ 
device [4]. Because accurate measure-
ments strongly rely on fast and accu-
rate sensors, micro-mechanical tech-
nology, and computer power, recently 
an even more reliable device has been 
developed that better complies with 
clinical requirements. The first next 
generation device, the Nexfin monitor 
is commercially available since 2007. 
A disposable cuff with an integrated 
photo-plethysmograph is placed 
around one finger. When light is emit-
ted through the finger, the infrared 
absorption fluctuates with the cardiac 
cycle, with higher absorption during 
systole. The resulting absorption curve 
(≈plethysmogram) can be appreciated 
as a measure for arterial blood volume 
in the finger. The essence of the vol-
ume clamp method is to dynamically 
provide equal pressures on either side 
of the wall of the artery by clamping 
the artery to a certain constant vol-
ume. As a first calibration step, the cuff 
is automatically inflated and the de-
vice searches for the optimal cuff pres-
sure for reliable measurement. This is 
the level of ‘vascular unloading’: with-
in this small pressure range, there is no 
transmural pressure gradient over the 
vessel wall. This is accomplished by 
the ‘Physiocal®’ algorithm, developed 
by Wesseling et al.[4] At that moment, 
the pressure in the cuff is close to the 
mean arterial pressure (MAP). Then, 
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the diameter of the finger artery un-
der the cuff is ‘clamped’ at that level, 
i.e. it is kept at a constant diameter 
in the presence of changes of arterial 
pressure during a cardiac cycle. To 
accomplish this, the light absorption is 
measured by the plethysmograph and 
the pressure in the cuff is adapted at a 
rate of 1000 Hertz, to apply the exact 
counter pressure in the cuff to prevent 
volume change. This in turn results 
in a constant infrared absorption (an 
apparent flat line plethysmogram, see 
Figure 2). When this is accomplished, 
the continuously varying pressure in 
the cuff equals the intra-arterial pres-
sure wave.
The unloaded volume of an artery is 
not constant, however, and changes 
with arterial wall smooth muscle stress 
and tone. Therefore the Physiocal® 
analysis (see Figure 2) is automati-
cally performed recurrently, to follow 
changing physiological states of the 
vasculature and keep the artery at its 
‘unloaded’ volume.  
At this stage, the device has acquired 
the arterial pressure waveform at the 
finger. A reliable waveform transforma-
tion is then applied to reconstruct the 
arterial pressure wave at the brachial 
level [6] (see Figure 3), since that is the 
clinical standard for noninvasive blood 
pressure measurement, which is usually 
performed with a cuff around the upper 
arm. When the hand is not at the heart 
level, an additional small ‘heart refer-
ence system’ is located at the level of the 
finger and the heart to compensate for 
the hydrostatic pressure difference. 
Cardiac output modeling
In order to determine beat-to-beat 
stroke volume from the arterial pres-
sure waveform, a pulse contour analysis 
is performed. The fundamental princi-
ple of this calculation is based on deter-
mination of the area below the systolic 
part of the arterial pressure curve and 
a three-element Windkessel model to 
determine cardiac afterload.
The physiologically three distinct ele-
ments that govern the relationship be-
tween pressure and flow can succinctly 
be explained as:
1.  The inertia of the blood (Z). It takes 
energy to accelerate the blood dur-
ing systole, and the accumulated 
kinetic energy keeps the blood flow-
ing during diastole. 
2.  The compliance of aorta and large 
arteries (C). During systole, the 
stroke volume is ejected in the elas-
tic arterial system, which expands 
and “accepts” part of the blood 
volume, reducing the systolic pres-
sure peak. This ‘stored energy and 
volume’ is released during diastole, 
sustaining diastolic pressure and 
flow.
3.  Peripheral vascular resistance (R), 
representing the resistance to out-
flow of blood to all vascular beds. 
During ejection into the blood-filled 
proximal aorta, the left heart encoun-
ters the combined effects of the proxi-
mal aortic compliance and its blood 
mass, or inertance. This combined 
effect is called the characteristic im-
pedance. Inertance increases the re-
sistance to ejection while compliance 
facilitates ejection.
For easy comprehension, these three 
elements can be depicted by their 
electronic equivalents (see Figure 4). 
While Z and C can vary moderately for 
a given patient, R varies greatly with 
changing physiological states.
Wesseling et al. [7] developed a work-
ing algorithm to derive cardiac output 
from the arterial pressure curve using 
the three-element Windkessel model. 
The characteristic impedance (Z) and 
total arterial compliance (C) are given 
as nonlinear functions of pressure 
based on gender, age, body length and 
weight. An initial value for peripheral 
resistance is calculated based on these 
characteristics. Stroke volume (SV) 
is then calculated from the arterial 
pressure curve (see Figure 5) and the 
estimated afterload. Cardiac output 
(CO) is derived as SV x HR and total 
peripheral resistance (TPR) is calculat-
ed as MAP/CO. This resistance value 
Figure 1 A disposable cuff with integrated photo-plethysmograph is placed around one finger. 
Three different dimensions of cuff exist to fit fingers from small to (very) large adults.
Figure 2 Continuous adaptation of the cuff pressure results in an apparent flat-line 
plethysmogram. The pressure in the cuff then reflects intra-arterial pressure. Periodic Physiocal 
recalibration allows accurate tracking of significant changes in vascular physiological states.
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is inserted again in the three-element 
windkessel and SV for the next beat 
is calculated based on this new TPR. 
After a few beats, convergence is ob-
tained and the true resistance is found: 
MAP/TPR = CO. The non-linear be-
havior of the compliance and charac-
teristic impedance combined with the 
adaptive peripheral resistance assure 
excellent tracking afterload and there-
fore of cardiac output [8, 9]. 
Dynamic preload variables
At this stage, beat-to-beat systolic, 
mean and diastolic blood pressures 
are determined, as well as stroke 
volume, cardiac output and total 
peripheral resistance. These variables 
yet have a poor ability to predict fluid 
responsiveness as a prerequisite for 
guiding fluid therapy. Since central 
venous pressure, blood pressure or 
heart rate have failed to predict fluid 
responsiveness, the availability of a 
simple variable that can fairly well 
predict how a patient will respond 
to fluid administration is profoundly 
appealing. The Frank-Starling law of 
the heart (see Figure 6) describes the 
relation between stroke volume and 
filling and can be used to maximize 
stroke volume of an individual by 
achieving an ‘optimal cardiac preload’. 
Although this ‘optimal preload’ cor-
responds with a certain central venous 
pressure (or PCWP for the left heart) 
for a given patient, its numerical value 
depends on several unpredictable vari-
ables (such as diastolic function) and 
therefore lacks any predictive value 
[10]. 
Importantly, however, intrathoracic 
pressure variations induced by positive 
pressure ventilation affect the end-dia-
stolic volume in a predictable manner. 
Figure 6 illustrates that the changes in 
stroke volume associated with venti-
lation-induced changes in preload are 
predictably determined by the position 
of the heart on the Frank-Starling rela-
tionship. As a consequence, the degree 
of variation in stroke volume through-
out the ventilatory cycle can reliably 
determine the position of the heart on 
its particular Frank-Starling relation-
ship and can therefore predict fluid re-
sponsiveness of the individual patient. 
Although some limitations exist on 
the use of this principle (such as posi-
tive pressure ventilation in a volume-
controlled matter and with sufficient 
tidal volume, regular heart rhythm, and 
acceptable lung compliance), the use of 
a dynamic preload variable can be very 
advantageous to optimise fluid man-
agement in most ventilated patients. 
The ccNexfin monitor calculates stroke 
volume variation (SVV) and pulse pres-
sure variation (PPV) continuously as 
the relative variation over a 15 second 
period: SVV = (SVmax – SVmin) /SVaverage; 
PPV = (PPmax-PPmin)/PPaverage. This 
averaging window is moved every 5 
seconds and the values displayed on the 
monitor represent a 1-minute average. 
Depending on the specific comorbidity 
and nature of the surgical procedure, 
the anesthetist will have to decide what 
position on the Frank-Starling relation-
ship is most beneficial for this specific 
patient – in most cases between 5 and 
15% PPV or SVV. After this clinical deci-
sion is made, SVV or PPV can facilitate 
optimal fluid administration to reach 
this goal.
Reliability of the Nexfin monitor
Both ccNexfin blood pressure and 
cardiac output have been validated 
against various reference methods. 
Recent studies comparing Nexfin 
against auscultatory blood pressure 
measurement [11] or invasive radial 
artery measurement [12] demonstrated 
excellent correlations and good within-
subject precision over wide ranges of 
pressures. In addition, bias and preci-
sion were within AAMI criteria [13] 
in a variety of hemodynamic states. 
The main limitation of the Nexfin is 
that adequate flow in the finger is im-
perative. In general however, relative 
changes in blood pressure had been 
considered reliable even in the earlier 
devices [14]. A validation study of the 
Nexfin CO in septic shock patients 
showed poor results, most likely 
because of compromised peripheral 
flow [15]. In non-septic patients, the 
accuracy of cardiac output measure-
ment by ccNexfin was compared to a 
thermodilution reference and shown 
to be a “reliable method of measuring 
cardiac output during and after cardiac 
surgery” [16]. Other studies comparing 
Nexfin CO measurements with those 
obtained by echo Doppler [17] or by 
inert gas-rebreathing [18] showed good 
correlations.  Correspondingly, assess-
ment of cardiac output with Nexfin is 
not considered completely accurate, 
particularly in critically ill patients, 
and therefore more invasive techniques 
may be more appropriate in these cases. 
A recent study [19] comparing Nexfin 
CO with transesophageal doppler 
showed a strong correlation and excel-
lent tracking of changes in CO after 
phenylephrine administration. Others 
concluded that Nexfin is a reliable 
method to measure CO during cardiac 
surgery [16]. In a recent study [20], we 
evaluated the ability of SVV to predict 
effective changes in cardiac output and 
blood pressure after administration of a 
fluid load of 500 ml, and demonstrated 
that the Nexfin can reliably predict to 
what degree there will be an increase 
of these variables in a heterogeneous 
patient population.
Figure 3 Pressure waves along arterial tree.
 
Figure 4 Electronic equivalence of the three-element 
windkessel model. 
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Use of the Nexfin monitor  
in daily practice
The Nexfin monitor permits com-
pletely noninvasive continuous 
monitoring of hemodynamics in a 
large patient population, which is 
comparatively poorly monitored as 
of yet. In addition, in some patients 
conventional NIBP may be impossible 
(burns, dialysis patients with shunts, 
fractures, …). While in obese patients 
measurement of conventional nonin-
vasive blood pressure by arm cuff may 
be difficult or unreliable, the Nexfin 
may be a good alternative since fingers 
usually do not fatten up so that the 
finger cuff still fits.
Compared to invasive blood pressure 
measurement, the Nexfin monitor has 
obviously less accuracy, so that in criti-
cal patients it should not be considered 
a sound alternative until more research 
has been done. In our own evaluation 
[21] we demonstrated an accuracy of 
±10 mmHg in 90% of the patients. This 
accuracy moreover was significantly 
better than conventional non-invasive 
blood pressure measurement by arm 
cuff so that, in addition to the obvious 
advantage of continuous measurement, 
the Nexfin could serve a superior alter-
native for noninvasive blood pressure 
recording. This is in agreement with a 
recent study showing that continuous 
blood pressure monitoring obtained 
by Nexfin allows for shorter delay in 
response to perioperative hypoten-
sion in comparison to conventional 
intermittent NIBP measurements [22]. 
Therefore Nexfin provides superior 
blood pressure monitoring compared 
to conventional NIBP, even if the more 
advanced hemodynamic information is 
not considered. Whether this will posi-
tively impact patient outcome is yet to 
be proven, but this may be expected.
Likewise, in our experience the ac-
curacy of stroke volume and systemic 
vascular resistance is definitely ap-
propriate to assist decision-making 
and optimise hemodynamic and fluid 
management. More importantly, while 
absolute values of these variables may 
sometimes deviate significantly from 
actual numbers, the high reliability of 
relative changes in response to inter-
ventions or events provides essential 
information to refine hemodynamic 
and fluid management.
There are some limitations for the use 
of the Nexfin monitor. Most impor-
tantly, any circumstances that severely 
reduce the blood flow in the fingers 
decreases the reliability of Nexfin, as 
in septic patients or patients receiving 
very high doses of vasoconstricting 
agents. But also low temperature of the 
hands is in our experience a common 
reason for unreliable measurements. 
The proprietary algorithms however 
can detect unreliable signal quality, 
and will try to recalibrate the system 
in such events. Generally, an interval 
between Physiocal calibrations of more 
than 30 beats is an accepted indicator 
for reliable measurement [4].  
After initiation of measurements, fre-
quent recalibration is necessary until 
stable values are found. Pressure and 
flow values are typically available with-
in approximately 1 min after starting 
the measurement, and SVV and PPV 
1 minute thereafter. In patients with 
rather cold hands, the Nexfin often 
fails to obtain measurements while 
awake, but a few minutes after induc-
tion of anesthesia and subsequent arte-
rial vasodilation, reliable data become 
available. Keeping patients warm in 
the preoperative stage can prevent this 
difficulty, although this may not always 
be possible.
Nevertheless, in a very large majority 
of patients, reliable values are avail-
able within a mere seconds, which is 
even faster than conventional NIBP.  
Just like any anesthetist intuitively 
feels with other variables such as SpO2 
or end-tidal CO2 where some clinical 
experience must be gained to visually 
appreciate the waveforms and assess 
the reliability of the numerical values, 
this is also true for the Nexfin monitor, 
where the waveform representation 
permits a straightforward approach to 
evaluate sensor reliability.
History and future
The Nexfin monitor is based on Dutch 
technology, first developed within a 
TNO (Nederlandse Organisatie voor 
toegepast natuurwetenschappelijk 
onderzoek) project to monitor astro-
nauts, then further commercialized 
by BMEYE (Amsterdam).  In 2012, 
Edwards Lifesciences acquired BMEYE 
and the technology will be further 
developed and commercialized by 
Edwards. The design of the ccNexfin 
monitor will remain unchanged for the 
time being, while probably in 2014 a 
Nexfin-module will become available 
for the EV1000 monitor platform of 
Edwards. In addition to reusable finger 
cuffs, disposable cuffs will become 
available soon.  Besides, we believe 
that any additional electronic device 
in an already overcrowded operating 
theatre restricts its convenient use, 
hence a modular device to fit in the 
existing anesthesia monitors would be 
of significant practical advantage and 
even essential to establish universal 
implementation. 
Figure 5 The parameters of the three-element windkessel 
model are calculated from demographic data and the 
reconstructed arterial pressure waveform: SV is a 
function of Z and the pressure-time integral of the systolic 
pressure wave (yellow area). 
Figure 6 Ventilation-induced oscillation in preload result 
in a variable oscillation of stroke volume. These stroke 
volume variations (SVV) reliably reflect the position of the 
heart on the Frank-Starling relationship (A). 
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